Pediatric Sedative Syrup Franchise in Ahmedabad

Triclofos Syrup Supplier in Mumbai

Triclofos Syrup Distributor in Delhi

Pediatric Hypnotic Syrup Manufacturer in Bangalore

Sedative Syrup Stockist in Hyderabad
Triclofos Syrup Exporter in Chandigarh

Home/Products /triclofos-500mg-5ml-syrup

Tofosleep Syrup

Composition : Triclofos (500mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 30ml

Price : ₹190/-

Tofosleep Syrup contains Triclofos 500mg/5ml, a well-established sedative and hypnotic agent primarily used in pediatric practice. It is commonly prescribed for short-term sedation and sleep induction, especially in children requiring calmness before diagnostic or therapeutic procedures.

Triclofos acts by depressing the central nervous system, producing a calming and sleep-inducing effect without significantly affecting respiratory function when used at recommended doses. Its predictable onset and duration make it a preferred choice for controlled pediatric sedation.

Clinically, Tribud Syrup is indicated for insomnia in children, pre-procedural sedation, EEG studies, imaging procedures, and minor interventions. The syrup formulation ensures accurate dosing, palatability, and ease of administration, making it suitable for pediatric patients under strict medical supervision.

Regular and judicious use helps in reducing anxiety, inducing restful sleep, and ensuring smooth completion of diagnostic or therapeutic procedures. Tribud Syrup remains a trusted pediatric sedative, offering safety, efficacy, and reliability in hospital and clinical settings.


Read More

About the Product

Tofosleep Syrup contains Triclofos 500mg/5ml, a well-established sedative and hypnotic agent primarily used in pediatric practice. It is commonly prescribed for short-term sedation and sleep induction, especially in children requiring calmness before diagnostic or therapeutic procedures.

Triclofos acts by depressing the central nervous system, producing a calming and sleep-inducing effect without significantly affecting respiratory function when used at recommended doses. Its predictable onset and duration make it a preferred choice for controlled pediatric sedation.

Clinically, Tribud Syrup is indicated for insomnia in children, pre-procedural sedation, EEG studies, imaging procedures, and minor interventions. The syrup formulation ensures accurate dosing, palatability, and ease of administration, making it suitable for pediatric patients under strict medical supervision.

Regular and judicious use helps in reducing anxiety, inducing restful sleep, and ensuring smooth completion of diagnostic or therapeutic procedures. Tribud Syrup remains a trusted pediatric sedative, offering safety, efficacy, and reliability in hospital and clinical settings.


Common side effects may include drowsiness, dizziness, mild nausea, or headache. Rarely, paradoxical reactions such as restlessness or irritability may occur, particularly in children.

Tofosleep Syrup is indicated for the management of insomnia and for inducing sedation in children during diagnostic or therapeutic procedures, as advised by a physician.

For oral use only. Use strictly under medical supervision. Measure the dose accurately using a calibrated device. Avoid concurrent use with other sedatives unless prescribed. Inform your doctor if the patient has liver disease, respiratory disorders, or hypersensitivity to Triclofos.

Store below 25°C in a cool, dry place. Protect from light. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation